1. Home
  2. CSQ vs STVN Comparison

CSQ vs STVN Comparison

Compare CSQ & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Strategic Total Return

CSQ

Calamos Strategic Total Return

HOLD

Current Price

$20.20

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.22

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSQ
STVN
Founded
2003
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Finance Companies
Containers/Packaging
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CSQ
STVN
Price
$20.20
$19.22
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
188.6K
304.7K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
7.53%
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.67
Revenue Next Year
N/A
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$16.41
$12.89
52 Week High
$20.86
$28.00

Technical Indicators

Market Signals
Indicator
CSQ
STVN
Relative Strength Index (RSI) 46.28 54.53
Support Level $20.08 $13.58
Resistance Level $20.75 $19.41
Average True Range (ATR) 0.28 0.81
MACD -0.03 0.06
Stochastic Oscillator 26.25 65.46

Price Performance

Historical Comparison
CSQ
STVN

About CSQ Calamos Strategic Total Return

Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: